SMLR News and Press, Semler Scientific Inc From 08/03/22

Shares of Semler Scientific (NASDAQ: SMLR) are skyrocketing today, up by 19.1% as of 10:50 a.m. ET. The big gain came after the healthcare technology company announced its second-quarter results following the market close on Tuesday. Semler reported Q2 revenue of $14.8 million, ...

The following slide deck was published by Semler Scientific, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Semler Scientific, Inc. 2022 Q2 - Results - Earnings Call Presentation

Semler Scientific, Inc. (SMLR) Q2 2022 Earnings Conference Call August 02, 2022, 16:30 ET Company Participants Douglas Murphy-Chutorian - CEO, Corporate Secretary & Director Renae Cormier - Head, Corporate Communication and Business Strategy Andrew Weinstein ...

Semler Scientific press release ( NASDAQ: SMLR ): Q2 GAAP EPS of $0.51 beats by $0.11 . Revenue of $14.83M (+3.6% Y/Y) beats by $0.12M . Cash and cash equivalents at June 30, 2022 increased to $40.0 million from $28.5 million. 2H Guidance: Revenue will...

Semler Reports Second Quarter and First Half of 2022 Financial Results PR Newswire 2022 Q2 quarterly HIGHLIGHTS compared to the corresponding period of 2021: Revenues were $14.8 million , an increase of 4%, compared to $14.3 million Net income w...

Semler Scientific's stock value has fallen from about $150 per share in November of 2021 to around $30 per share. Yet, the company continues to report growth and is profitable. I believe the market has taken the selling too far and is overlooking the company’s unique product an...

Semler to Report Second Quarter and First Half 2022 Financial Results and Host Conference Call on August 2, 2022 PR Newswire SANTA CLARA, Calif. , July 21, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology sol...

Semler Scientific (NASDAQ:SMLR) stock has slid 24.1% to $35.94 in Tuesday late afternoon trade, after the healthcare technology products company posted Q1 2022 earnings that missed expectations. SMLR's Q1 GAAP EPS of $0.41 missed estimates by $0.07 while revenue of ~$14M fell short by $500K. ...

Gainers: Sonoma Pharmaceuticals (SNOA) +29%. Blue Water Vaccines (BWV) +32%. XORTX Therapeutics (XRTX) +27%. Eqonex  (EQOS) +21%. TETRA Technologies (TTI) +20%. Enovix (ENVX) +18%. JAKKS Pacific (JAKK) +18%. Blue Apron Holdings (APRN) +17%. Borr Drilling (BORR) +16%. Western Digital Corp...

Shares of Semler Scientific (NASDAQ: SMLR) were sinking 23.1% as of 10:33 a.m. ET on Tuesday. The steep decline came after the medical technology company reported its first-quarter results following the market close on Monday. Semler announced Q1 revenue of $14 million, up 6% ye...